Clinical Trial Update: Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone [Phase 1]

View source ↗

Summary

Phase 1 drug interaction study evaluating atazanavir with and without ritonavir and rosiglitazone in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Avandia (rosiglitazone)
• Norvir (ritonavir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 1 | Status: COMPLETED